Home Cart Sign in  
Chemical Structure| 39674-97-0 Chemical Structure| 39674-97-0

Structure of BVT948
CAS No.: 39674-97-0

Chemical Structure| 39674-97-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BVT 948 is a non-competitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTPs) with IC50 of 0.09 - 1.7 μM, displaying irreversible inhibition through catalysis of the hydrogen peroxide-dependent oxidation of PTP. BVT 948 enhances insulin signaling in vitro and insulin tolerance in ob/ob mice in vivo.

Synonyms: BVT948

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BVT948

CAS No. :39674-97-0
Formula : C14H11NO3
M.W : 241.24
SMILES Code : O=C(C(C)(C)C1=C2O)N=C1C3=CC=CC=C3C2=O
Synonyms :
BVT948
MDL No. :MFCD00616487
InChI Key :LLPBUXODFQZPFH-UHFFFAOYSA-N
Pubchem ID :6604934

Safety of BVT948

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317
Precautionary Statements:P280

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 5 μM 3 days Inhibition of SETD8's methyltransferase activity, leading to rapid depletion of H4K20me1 mark ACS Chem Biol. 2014 Nov 21;9(11):2471-8
MCF-7 cells 1 μM and 5 μM 24 h To study the effect of BVT948 on TPA-induced MMP-9 expression, showing dose-dependent inhibition of TPA-induced MMP-9 mRNA and protein up-regulation. BMB Rep. 2013 Nov;46(11):533-8
MCF-7 cells 1 μM and 5 μM 24 h To investigate the cytotoxicity of BVT948 on MCF-7 cells, showing no significant changes in cell viability at 1 μM and 5 μM concentrations for 24 h. BMB Rep. 2013 Nov;46(11):533-8
HepG2 19.5–100 μM/mL 24 h To evaluate the cytotoxicity of BVT-948 and alexidine dihydrochloride. The EC50 value for BVT-948 was 39.8 μM with a selectivity index of 36. Int J Parasitol Drugs Drug Resist. 2022 Aug;19:81-88

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat Spared nerve injury (SNI) model Incubation in spinal cord slices 10 μM 60 min pretreatment followed by 2 min NMDA+D-Ser treatment BVT948 enhances NMDA receptor activation by augmenting phosphorylation of Tyr1472 on the NR2B subunit, thereby promoting NPY release as evidenced by increased Y1 receptor internalization. Neuropharmacology. 2019 Nov 1;158:107732

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.15mL

0.83mL

0.41mL

20.73mL

4.15mL

2.07mL

41.45mL

8.29mL

4.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories